![](https://endpts.com/wp-content/uploads/2022/03/Christopher-Austin-Vesalius-tile-scaled.jpg)
Christopher Austin, Vesalius CEO
Months after launching with lofty goal, Flagship startup streamlines ops, chops headcount
Even by Flagship Pioneering’s standards, the stated goal at Vesalius Therapeutics — unveiled at its launch this March — was exceedingly ambitious. Armed with $75 million …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.